"False"
Umeå University
printicon
Main menu hidden.
Staff photo Eva-Lotta Glader

Eva-Lotta Glader

Senior lecturer and chief physician in internal medicine and specialist in clinical pharmacology.
Teaches and researches in the field of vascular diseases, obesity and drug epidemiology.

Research qualifications: Docent

Contact

E-mail
eva-lotta.glader@umu.se
Phone
+46 90 786 59 00

Works at

Affiliation
Associate professor, senior consultant (attending) physician at Department of Public Health and Clinical Medicine Section: Angiology and stroke
Location
Byggnad 1A, plan 4, målpunkt B41, Norrlands universitetssjukhus, 459
Improved adherence to statin treatment and differences in results between men and women after pictorial risk communication: a sub-study of the VIPVIZA RCT
European Journal of Clinical Pharmacology, Springer 2024, Vol. 80, (8) : 1209-1218
Holmberg, Henrik; Glader, Eva-Lotta; Näslund, Ulf; et al.
Intensive lifestyle intervention for cardiometabolic prevention implemented in healthcare: higher risk predicts premature dropout
American Journal of Lifestyle Medicine
Krachler, Benno; Söderholm, Anna; Ekman, Fanny; et al.
Socioeconomic differences in patient reported outcome measures 3 months after stroke: a nationwide Swedish register-based study
Stroke, Lippincott Williams & Wilkins 2024, Vol. 55, (8) : 2055-2065
Lindmark, Anita; von Euler, Mia; Glader, Eva-Lotta; et al.
Longitudinal changes in self-reported medication adherence and beliefs about post-stroke medicines in Sweden: a repeated cross-sectional study
BMJ Open, BMJ Publishing Group Ltd 2024, Vol. 14, (10)
Sjölander, Maria; Gustafsson, Maria; Holmberg, Henrik; et al.
Exploring medication-related hospital admissions and their association with cognitive impairment among acutely admitted older people
Research in Social and Administrative Pharmacy, Elsevier 2023, Vol. 19, (7) : 1048-1053
Kindstedt, Jonas; Andersson, Pernilla; Westberg, Annica; et al.
The impact of nursing home residency on psychotropic drug use in major neurocognitive disorder: a nationwide comparison
International Journal of Geriatric Psychiatry, John Wiley & Sons 2023, Vol. 38, (11)
Kindstedt, Jonas; Glader, Eva-Lotta; Lövheim, Hugo; et al.
Are doctors using more preventive medication for cardiovascular disease?: A Swedish cross-sectional study
Scandinavian Journal of Primary Health Care, Taylor & Francis 2023, Vol. 41, (3) : 297-305
Lillqvist, Joel; Nilsson Sommar, Johan; Gustafsson, Per E; et al.
Time to initiation of lipid-lowering drugs for subclinical atherosclerosis: sub-study of VIPVIZA randomized controlled trial, with single-arm cross-over
European Heart Journal Open, Oxford University Press 2022, Vol. 2, (1)
Holmberg, Henrik; Sjölander, Maria; Glader, Eva-Lotta; et al.
Self-reported medication adherence and pharmacy refill adherence among persons with ischemic stroke: a cross-sectional study
European Journal of Clinical Pharmacology, Springer Science+Business Media B.V. 2022, Vol. 78 : 869-877
Norberg, Helena; Sjölander, Maria; Glader, Eva-Lotta; et al.
Primary Non-Adherence to Preventive Drugs and Associations with Beliefs About Medicines in Stroke Survivors
Patient Preference and Adherence, Dove Medical Press 2022, Vol. 16 : 343-352
Westberg, Annica; Sjölander, Maria; Glader, Eva-Lotta; et al.
In-hospital delays in stroke thrombolysis: every minute counts
Stroke, American Heart Association 2020, Vol. 51, (8) : 2536-2539
Darehed, David; Blom, Mathias; Glader, Eva-Lotta; et al.
Investigating the effect of clinical pharmacist intervention in transitions of care on drug-related hospital readmissions among the elderly: study protocol for a randomised controlled trial
BMJ Open, BMJ Publishing Group Ltd 2020, Vol. 10, (4)
Kindstedt, Jonas; Svahn, Sofia; Sjölander, Maria; et al.
STudy of Antithrombotic Treatment after IntraCerebral Haemorrhage: Protocol for a randomised controlled trial
European Stroke Journal, Sage Publications 2020, Vol. 5, (4) : 414-422
Larsen, Kristin Tveitan; Forfang, Elisabeth; Pennlert, Johanna; et al.
Effect of early supported discharge after stroke on patient reported outcome based on the Swedish Riksstroke registry
BMC Neurology, BioMed Central 2019, Vol. 19
Bråndal, Anna; Eriksson, Marie; Glader, Eva-Lotta; et al.
Diurnal variations in the quality of stroke care in Sweden
Acta Neurologica Scandinavica, John Wiley & Sons 2019, Vol. 140, (2) : 123-130
Darehed, David; Blom, Mathias; Glader, Eva-Lotta; et al.
Time Trends and Monthly Variation in Swedish Acute Stroke Care
Frontiers in Neurology, Frontiers Media S.A. 2019, Vol. 10
Darehed, David; Blom, Mathias; Glader, Eva-Lotta; et al.
Acute stroke patients are subject to seasonal variation in quality of care and survival: a Swedish nationwide registry-based study
International Journal of Stroke, Sage Publications 2018, Vol. 13 : 177-177
Darehed, David; Blom, M.; Glader, Eva-Lotta; et al.
Acute stroke alert activation, emergency service use, and reperfusion therapy in Sweden
Brain and Behavior, Vol. 7, (4)
Eriksson, Marie; Glader, Eva-Lotta; Norrving, Bo; et al.
Socioeconomic factors' effect on return to work after first stroke
Acta Neurologica Scandinavica, John Wiley & Sons 2017, Vol. 135, (6) : 608-613
Glader, Eva-Lotta; Jonsson, B.; Norrving, B.; et al.
Socioeconomic Status and the Risk of Stroke Recurrence: Persisting Gaps Observed in a Nationwide Swedish Study 2001 to 2012.
Stroke, Vol. 48, (6) : 1518-1523
Pennlert, Johanna; Asplund, Kjell; Glader, Eva-Lotta; et al.
Associations between Ischemic Stroke Follow-Up, Socioeconomic Status, and Adherence to Secondary Preventive Drugs in Southern Sweden: Observations from the Swedish Stroke Register (Riksstroke)
Neuroepidemiology, S. Karger 2017, Vol. 48, (1/2) : 32-38
Ullberg, Teresa; Glader, Eva-Lotta; Zia, Elisabet; et al.
The Importance of Integrating Clinical Relevance and Statistical Significance in the Assessment of Quality of Care - Illustrated Using the Swedish Stroke Register
PLOS ONE, Vol. 11, (4)
Lindmark, Anita; van Rompaye, Bart; Goetghebeur, Els; et al.
Inequalities in medication adherence to statin treatment after stroke: A nationwide observational study
European Stroke Journal, Sage Publications 2016, Vol. 1, (2) : 101-107
Sjölander, Maria; Eriksson, Marie; Glader, Eva-Lotta
Validation of Hospital Performance Measures of Acute Stroke Care Quality. Riksstroke, the Swedish Stroke Register
Neuroepidemiology, Vol. 46, (4) : 229-234
Söderholm, Anna; Stegmayr, Birgitta; Glader, Eva-Lotta; et al.
Post-stroke suicide attempts and completed suicides: A socioeconomic and nationwide perspective
International Journal of Stroke, Vol. 10 : 33-33
Eriksson, Marie; Glader, Eva-Lotta; Norrving, B.; et al.
Poststroke suicide attempts and completed suicides: a socioeconomic and nationwide perspective
Neurology, Vol. 84, (17) : 1732-1738
Eriksson, Marie; Glader, Eva-Lotta; Norrving, Bo; et al.
Kvalitetsregistret Riksstroke visar på ojämlik strokevård: omedveten diskriminering kanske förklarar en del av skillnaderna
Läkartidningen, Läkartidningen Förlag AB 2015, Vol. 112
Eriksson, Marie; Glader, Eva-Lotta; Norrving, Bo; et al.
Socioeconomic status predicts return to work after first stroke in younger adults
International Journal of Stroke, Vol. 10 : 174-174
Glader, Eva-Lotta; Jonsson, B.; Eriksson, Marie
Socioeconomic Inequalities in the Prescription of Oral Anticoagulants in Stroke Patients With Atrial Fibrillation
Stroke, Vol. 46, (8) : 2220-2225
Sjölander, Maria; Eriksson, Marie; Asplund, Kjell; et al.
Trends in Stroke Treatment and Outcome between 1995 and 2010: Observations from Riks-Stroke, the Swedish Stroke Register
Cerebrovascular Diseases, Vol. 37, (1) : 22-29
Appelros, Peter; Jonsson, Fredrik; Asberg, Signild; et al.
Costs for stroke in Sweden 2009 and developments since 1997
International Journal of Technology Assessment in Health Care, Vol. 30, (2) : 203-209
Ghatnekar, Ola; Persson, Ulf; Asplund, Kjell; et al.
Socioeconomic disparities in stroke case fatality: observations from Riks-Stroke, the Swedish stroke register
International Journal of Stroke, John Wiley & Sons 2014, Vol. 9, (4) : 429-436
Lindmark, Anita; Glader, Eva-Lotta; Asplund, Kjell; et al.
Education level and inequalities in stroke reperfusion therapy: observations in the Swedish stroke register
Stroke, American Heart Association 2014, Vol. 45, (9) : 2762-2768
Stecksén, Anna; Glader, Eva-Lotta; Asplund, Kjell; et al.
Implementing thrombolytic guidelines in stroke care: perceived facilitators and barriers
Qualitative Health Research, Sage Publications 2014, Vol. 24, (3) : 412-419
Stecksén, Anna; Lundman, Berit; Eriksson, Marie; et al.
Mapping health outcome measures from a stroke registry to EQ-5D weights
Health and Quality of Life Outcomes, London, England: BioMed Central 2013, Vol. 11, (34)
Ghatnekar, Ola; Eriksson, Marie; Glader, Eva-Lotta
The societal cost of stroke in Sweden 2009 and developments since 1997
Cerebrovascular Diseases, Vol. 35, (Suppl. 3) : 475-475
Ghatnekar, Ola; Glader, Eva-Lotta; Persson, U; et al.
More equal stroke unit care over time. A 15-year follow up of socioeconomic disparities in stroke unit care in Sweden
Cerebrovascular Diseases, Vol. 35, (Suppl. 3) : 702-702
Glader, Eva-Lotta; Edlund, Hilda; Sukhova, M; et al.
Reduced inequality in access to stroke unit care over time: a 15-year follow-up of socioeconomic disparities in Sweden
Cerebrovascular Diseases, S. Karger 2013, Vol. 36, (5-6) : 407-411
Glader, Eva-Lotta; Edlund, Hilda; Sukhova, Maria; et al.
Socioeconomic disparities in stroke case fatality: observations from Riks-Stroke, the Swedish stroke register
Cerebrovascular Diseases, Vol. 35, (Suppl. 3) : 225-225
Lindmark, Anita; Glader, Eva-Lotta; Asplund, Kjell; et al.
The association between patients' beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey
BMJ Open, Vol. 3, (9)
Sjölander, Maria; Eriksson, Marie; Glader, Eva-Lotta
Social stratification in the dissemination of statins after stroke in Sweden
European Journal of Clinical Pharmacology, Heidelberg: Springer Berlin/Heidelberg 2013, Vol. 69, (5) : 1173-1180
Sjölander, Maria; Eriksson, Marie; Glader, Eva-Lotta
Socioeconomic inequalities in access to stroke thrombolysis: observations in the Swedish stroke register (Riks-Stroke)
Cerebrovascular Diseases, Basel, Switzerland: S. Karger 2013, Vol. 35, (Suppl. 3) : 671-671
Stecksén, Anna; Asplund, Kjell; Glader, Eva-Lotta; et al.
Few sex differences in the use of drugs for secondary prevention after stroke: a nationwide observational study
Pharmacoepidemiology and Drug Safety, San Francisco: John Wiley & Sons 2012, Vol. 21, (9) : 911-919
Sjölander, Maria; Eriksson, Marie; Glader, Eva-Lotta
Thrombolytic therapy rates and stroke severity: an analysis of data from the Swedish Stroke Register (Riks-Stroke) 2007-2010
Stroke, New York: American Heart Association 2012, Vol. 43, (2) : 536-538
Stecksén, Anna; Asplund, Kjell; Appelros, Peter; et al.
Effects of Extending the Time Window of Thrombolysis to 4.5 Hours: Observations in the Swedish Stroke Register (Riks-Stroke)
Stroke, New York: American Heart Association 2011, Vol. 42, (9) : 2492-2497
Asplund, Kjell; Glader, Eva-Lotta; Norrving, Bo; et al.
Implementation in routine clinical practice of thrombolysis in extended time window 3-4.5 h: A nationwide swedish study
Special Issue: Abstracts of the 15th Congress of the EFNS, Budapest, Hungary, 2011, Oxford: Rapid Communications 2011 : 52-52
Asplund, Kjell; Norrving, B.; Glader, Eva-Lotta; et al.
Few sex differences in use of drugs for secondary prevention after stroke: a nationwide observational study
Abstracts 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management Hyatt Regency Chicago: Chicago, Illinois, USA August 14–17, 2011, Wiley 2011 : S110-S110
Sjölander, Maria; Eriksson, Marie; Glader, Eva-Lotta
Trends in baseline patient characteristics during the years 1995-2008: observations from Riks-Stroke, the Swedish Stroke Register
Cerebrovascular Diseases, Vol. 30, (2) : 114-119
Appelros, Peter; Jonsson, Fredrik; Asplund, Kjell; et al.
Discarding heparins as treatment for progressive stroke in Sweden 2001 to 2008
Stroke, Vol. 41, (11) : 2552-2558
Eriksson, Marie; Stecksén, Anna; Glader, Eva-Lotta; et al.
Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke.
Stroke, American Heart Association 2010, Vol. 41, (2) : 397-401
Glader, Eva-Lotta; Sjölander, Maria; Eriksson, Marie; et al.
View publications in DiVA

Research projects

29 April 2013 until 31 December 2027
VIPVIZA
1 January 2012 until 31 December 2015
EqualStroke: Inequalities in Swedish stroke care with respect to socioeconomic status, country of birth, sex and age